Oramed CEO Joins Nano Dimension Board as Directors Weigh Capital Options
Nano Dimension (NNDM) has appointed Nadav Kidron, CEO of Oramed Pharmaceuticals (ORMP), to its Board of Directors. Kidron will chair a newly formed Strategy and Capital Allocation Committee. This committee will evaluate capital allocation alternatives, potential returns of excess capital, monetization of non-core assets, …